This study provides a comprehensive evaluation of the factors influencing OS among patients diagnosed with NSCLC, incorporating a wide spectrum of variables such as types of systemic therapy, driver oncogene mutations, and PD-L1 expression levels in the real-world settings. Here, CD274 is linked to non-small cell lung carcinoma.